NCCN Updates Non-Hodgkin ’s Lymphoma Guidelines

FORT WASHINGTON, Pa., April 22, 2008 — The National Comprehensive Cancer Network (NCCN) announces several new updates to the NCCN Clinical Practice Guidelines in Oncology Non-Hodgkin’s Lymphoma (NHL). These changes highlight leading developments in the treatment of NHL and represent the recognized standard for clinical care in onco logy in both the community and the academic practice settings. The NHL Guidelines now include bendamustine (Treanda, Cephalon) as a treatment option for chronic lymph...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news